FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:846-847 September 17, 1998 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

To the Editor: Recently, we have been deeply disturbed by the decision of several families to use alternative therapies exclusively as front-line treatment for their children's cancer, or to use alternative rather than adjuvant therapy after radical surgery. We report here on two patients, in both of whom we documented tumor growth after the use of alternative therapies.

Patient 1, a 15-year-old boy, received a diagnosis of stage IIA nodular, sclerosing Hodgkin's disease in April 1998. Treatment with multiagent chemotherapy and low-dose irradiation to the involved field was recommended. Despite lengthy discussion, the patient, with the approval of his mother, . . . [Full Text of this Article]

References

Related Letters:

Alternative Therapies in Childhood Cancer
Orbach O., Fernandez C., Pyesmany A., Stutzer C.
Extract | Full Text  
N Engl J Med 1999; 340:569-570, Feb 18, 1999. Correspondence

This article has been cited by other articles:

• Smolinske, S. C. (2005). Herbal Product Contamination and Toxicity. Journal of Pharmacy Practice 18: 188-208 [Abstract]  
• Cohen, M. H., Kemper, K. J. (2005). Complementary Therapies in Pediatrics: A Legal Perspective. Pediatrics 115: 774-780 [Abstract] [Full Text]  
• Markman, M. (2002). Safety Issues in Using Complementary and Alternative Medicine. JCO 20: 39s-41 [Abstract] [Full Text]  
• Ernst, E. (2001). Complementary Medicine: Its hidden risks. Diabetes Care 24: 1486-1488 [Full Text]  
• Ang-Lee, M. K., Moss, J., Yuan, C.-S. (2001). Herbal Medicines and Perioperative Care. JAMA 286: 208-216 [Abstract] [Full Text]  
• Ernst, E. (2001). Intangible Risks of Complementary and Alternative Medicine. JCO 19: 2365-2366 [Full Text]  
• Liepa, G. (2001). Editorial: Cardioprotective Effects of {omega}-3 Fatty Acids: A Critical Review That Should Be Read by a Wide Range of Health Professionals. Nutr Clin Pract 16: 5-5  
• Sardesai, V. M., Myers, T. (2001). Clinincal Observations: Nutrient Supplements in Clinical Care. Nutr Clin Pract 16: 35-45 [Abstract]  
• Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., Singletary, S. E. (2000). Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology. JCO 18: 2505-2514 [Abstract] [Full Text]  
• Ernst, E. (2000). Unconventional Cancer Therapies : What We Need Is Rigorous Research, Not Closed Minds. Chest 117: 307-308 [Full Text]  
• Rao, J. K., Mihaliak, K., Kroenke, K., Bradley, J., Tierney, W. M., Weinberger, M. (1999). Use of Complementary Therapies for Arthritis among Patients of Rheumatologists. ANN INTERN MED 131: 409-416 [Abstract] [Full Text]  
• Burstein, H. J., Gelber, S., Guadagnoli, E., Weeks, J. C. (1999). Use of Alternative Medicine by Women with Early-Stage Breast Cancer. NEJM 340: 1733-1739 [Abstract] [Full Text]  
• Orentlicher, D., Hehir, M. K. II (1999). Advertising Policies of Medical Journals: Conflicts of Interest for Journal Editors and Professional Societies. J Law Med Ethics 27: 113-121  
• Orbach, O., Fernandez, C., Pyesmany, A., Stutzer, C. (1999). Alternative Therapies in Childhood Cancer. NEJM 340: 569-570 [Full Text]  
• Angell, M., Kassirer, J. P. (1998). Alternative Medicine -- The Risks of Untested and Unregulated Remedies. NEJM 339: 839-841 [Full Text]